Clearside Biomedical Financial Overview
Clearside Biomedical's market cap is currently $19.37M. The company's EPS TTM is $-17.1; its P/E ratio is -0.68; Clearside Biomedical is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
